<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="738">
  <stage>Registered</stage>
  <submitdate>12/09/2005</submitdate>
  <approvaldate>12/09/2005</approvaldate>
  <nctid>NCT00163813</nctid>
  <trial_identification>
    <studytitle>The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study</studytitle>
    <scientifictitle>The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care Study</scientifictitle>
    <utrn />
    <trialacronym>ENTERIC</trialacronym>
    <secondaryid>232/04</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Critical Illness</healthcondition>
    <healthcondition>Malabsorption Syndromes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other metabolic disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Early jejunal feeding (using frictional NJ tube)
Treatment: surgery - Standard feeding (using nasogastric [NG] tube)

Treatment: surgery: Early jejunal feeding (using frictional NJ tube)


Treatment: surgery: Standard feeding (using nasogastric [NG] tube)


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The amount of EN delivered during the Intensive Care Unit (ICU) stay</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Amount of EN delivered during the first 10 days of the study</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Daily cumulative proportion of EN delivered</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Ventilator-associated pneumonia rate</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of mechanical ventilation</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of hospitalisation</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mortality at hospital discharge</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Success rate of placement into both the small bowel, generally, and the jejunum, specifically</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Complication rates (as compared to the nasogastric tube)</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ICU patients are eligible for enrolment if they meet all of the following:

          -  Age &gt; 18 years old

          -  In ICU for &lt; 48 hours prior to enrolment

          -  Receiving invasive mechanical ventilation (through an endotracheal tube or
             tracheostomy, but NOT a facemask) with an anticipated need for &gt; 48 hours of
             mechanical ventilation

          -  Receiving a continuous infusion of any one of:

               -  morphine &gt; 2 mg/hour,

               -  fentanyl &gt; 20 mcg/hour, or

               -  pethidine &gt; 20 mg/hour

          -  Either a single GRV &gt; 150 mls (whilst receiving EN via a NG tube) or nasogastric
             drainage &gt; 500 mls over 12 hours (whether receiving EN or not)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients will be ineligible for enrolment if they meet any of the following:

          -  Previous or recent surgery which has altered the anatomy of the upper gastrointestinal
             tract (eg. oesophagectomy, gastrectomy, any gastric anastomosis surgery, gastroplasty,
             pyloroplasty, pancreaticoduodenectomy [Whipples procedure])

          -  Known gastric malignancy

          -  Known oesophageal varices

          -  Current admission for peptic ulceration

          -  Current mechanical bowel obstruction

          -  Current gastrostomy, jejunostomy, or surgically-placed enteral tube in situ

          -  Contraindication to the use of the nose and mouth for enteral tube insertion (eg.
             recent facial trauma or surgery)

          -  Receiving nutritional support prior to ICU admission

          -  Severe coagulopathy (defined by platelet count &lt; 20 and/or international normalized
             ratio [INR] &gt; 4.0)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Alfred Hospital - Melbourne</hospital>
    <postcode>3181 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Bayside Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a multi-centre randomised controlled trial comparing early jejunal feeding (using a
      frictional nasojejunal [NJ] tube) and standard feeding in critical illness.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00163813</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Andrew Davies</name>
      <address>The Alfred</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Andrew Davies</name>
      <address />
      <phone>+61 3 92762607</phone>
      <fax />
      <email>a.davies@alfred.org.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>